CORNERSTONE THERAPEUTICS INC Business Finance Contracts & Agreements
46 Contracts & Agreements
- Credit Agreements (1 contract)
- Exchange Agreements (1)
- Guaranty Agreements (2)
- Investor Rights Agreements (1)
- Loan Agreements (4)
- Modification Agreements (3)
- Note Agreements (1)
- Purchase Agreements (8)
- Registration Rights Agreements (2)
- Security Agreements (3)
- Stock Agreements (16)
- Underwriting Agreements (1)
- Waiver Agreements (1)
- Warrant Agreements (2)
- CORNERSTONE THERAPEUTICS INC. Restricted Stock Agreement (Filed With SEC on November 7, 2013)
- CORNERSTONE THERAPEUTICS INC. Restricted Stock Agreement (Filed With SEC on May 9, 2013)
- AMENDED AND RESTATED DEVELOPMENT & MANUFACTURING AGREEMENT By and Between EKR THERAPEUTICS, INC. and BAXTER HEALTHCARE CORPORATION [***]Confidential portions of the exhibit have... (Filed With SEC on August 9, 2012)
- CREDIT AGREEMENT Dated as of June 21, 2012 among CORNERSTONE THERAPEUTICS INC., as the Borrower, CHIESI FARMACEUTICI S.P.A., as Administrative Agent, and The Other Lenders Party... (Filed With SEC on June 27, 2012)
- CONSENT AND WAIVER (Filed With SEC on May 15, 2012)
- ASSET PURCHASE AGREEMENT (Filed With SEC on May 15, 2012)
- ASSET PURCHASE AGREEMENT (Filed With SEC on May 15, 2012)
- EX-10.5 Second Amendment, dated July 27, 2009, to Amended and Restated Restricted Stock Agreement (Filed With SEC on November 4, 2009)
- Ex-10.1 Asset Purchase Agreement, dated July 13, 2009, between Oscient Pharmaceuticals Corporation and Cornerstone BioPharma, Inc (Filed With SEC on July 17, 2009)
- EX-10.5 First Amendment, dated June 12, 2009, to Amended and Restated Restricted Stock Agreement between Cornerstone BioPharma Holdings, Inc. and David Price dated October 31, 2008 (Filed With SEC on June 18, 2009)
- EX-10.6 Registration Rights Agreement, dated as of May 6, 2009 (Filed With SEC on May 12, 2009)
- EX-10.5 Registration Rights Agreement, dated as of May 6, 2009, by and between the Company and Chiesi Farmaceutici SpA (Filed With SEC on May 12, 2009)
- EX-10.1 Stock Purchase Agreement, dated as of May 6, 2009, by and between Chiesi Farmaceutici SpA and the Company (Filed With SEC on May 12, 2009)
- Ex-10.93 Restricted Stock Agreement dated as of September 16, 2008 between the Registrant and Scott B. Townsend (Filed With SEC on March 26, 2009)
- Ex-10.50 Security Agreement by Aristos Pharmaceuticals, Inc. and Cornerstone BioPharma Holdings, Inc. in favor of Paragon Commercial Bank dated June 25, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.49 Unconditional Guaranty by Aristos Pharmaceuticals, Inc. in favor of Paragon Commercial Bank dated June 25, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.48 Security Agreement by Cornerstone BioPharma, Inc. and Cornerstone BioPharma Holdings, Inc. in favor of Paragon Commercial Bank dated June 25, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.47 Unconditional Guaranty by Cornerstone BioPharma, Inc. in favor Paragon Commercial Bank dated June 25, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.46 Modification Agreement, dated June 25, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.44 Modification Agreement, dated July 31, 2007 (Filed With SEC on November 5, 2008)
- Ex-10.43 Modification Agreement, dated April 10, 2006 (Filed With SEC on November 5, 2008)
- Ex-10.42 Security Agreement by Cornerstone BioPharma Holdings, Inc. in favor of Paragon Commercial Bank dated April 21, 2005 (Filed With SEC on November 5, 2008)
- Ex-10.41 Commercial Note issued by Cornerstone BioPharma Holdings, Inc. to Paragon Commercial Bank dated April 21, 2005 (Filed With SEC on November 5, 2008)
- Ex-10.40 Form of Nonstatutory Employee Stock Option Agreement Granted Under the 2005 Stock Option Plan (Filed With SEC on November 5, 2008)
- Ex-10.38 Cornerstone BioPharma Holdings, Inc. 2005 Stock Option Plan (as Amended and Restated effective October 31, 2008) (Filed With SEC on November 5, 2008)
- Ex-10.34 Amended and Restated Restricted Stock Agreement between Cornerstone BioPharma Holdings, Inc. and David Price dated October 31, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.23 Amendment No. 3, dated December 7, 2006, to Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc (Filed With SEC on November 5, 2008)
- Ex-10.22 Amendment No. 2, dated November 13, 2006, to Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc (Filed With SEC on November 5, 2008)
- Ex-10.21 Amendment No. 2, dated November 16, 2005, to Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc (Filed With SEC on November 5, 2008)
- Ex-10.20 Amendment No. 1, dated May 20, 2005, to Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc. (as assignee of Cornerstone... (Filed With SEC on November 5, 2008)
- Ex-10.19 Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc. (as assignee of Cornerstone Biopharma, Ltd. (formerly known as Cornerstone... (Filed With SEC on November 5, 2008)
- Ex-4.1 Form of the Registrant's Stock Certificate (Filed With SEC on November 5, 2008)
- EX-10.2 - Warrant Agreement dated October 31, 2006 by and between Registrant and Mellon Investor Services (Filed With SEC on November 9, 2006)
- FORMOF WARRANT AGREEMENT (Filed With SEC on October 27, 2006)
- EX-10.1 FOURTH LOAN MODIFICATION AGREEMENT (Filed With SEC on May 10, 2006)
- Ex-10.24 The Fourth Loan Modification Agreement dated January 6, 2006 (Filed With SEC on March 7, 2006)
- Ex-10.29 Form of Nonstatutory Stock Option Agreement (Filed With SEC on March 17, 2005)
- Ex-10.28 Form of Restricted Stock Agreement (Filed With SEC on March 17, 2005)
- Ex-10.27 Form of Nonstatutory Stock Option Agreement (Filed With SEC on March 17, 2005)
- Ex-10.3 Form of Nonstatutory Stock Option Agreement (Filed With SEC on November 15, 2004)
